Vimarsana
Biggest News Aggregation in the World

Exevir Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Exevir Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Exevir Bio Today - Breaking & Trending Today

Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio - Vimarsana News

Nona Biosciences Enters into Collaboration Agreement with ExeVir Bio

/PRNewswire/ -- Nona Biosciences, a wholly-owned subsidiary of HBM Holdings Limited, committed to cutting-edge technology innovation and provider of integrated...

ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19 - Vimarsana News

ExeVir Bio and VIB Announce Data on a New Therapy for Prevention and Treatment for COVID-19

ExeVir Bio, a biotech company developing robust single domain antibody therapies for broad protection against infectious diseases, and its scientific founders at Belgium’s VIB, Flanders’ leading life sciences institute, today announced the publication of a pre-print paper by De Cae et al., entitled “Ultrapotent ...

ExeVir Bio Secures EUR 25M Venture Debt Financing - Vimarsana News

ExeVir Bio Secures EUR 25M Venture Debt Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors - Vimarsana News

ExeVir Bio Forges Ahead with Unique Next Generation COVID-19 Therapy and Appoints Dr. Jeanne Bolger as Chair of the Board of Directors

/PRNewswire/ -- ExeVir is developing robust therapies providing broad protection against infectious diseases, including coronaviruses. The company has...

Cantargia appoints Dr. Dominique Tersago as Chief Medical Officer - Vimarsana News

Cantargia appoints Dr. Dominique Tersago as Chief Medical Officer

LUND, Sweden, July 8, 2022 /PRNewswire/ -- Cantargia (Cantargia AB; Nasdaq Stockholm: CANTA) today announced...